study objective : to determine the efficacy of stepwise incremental doses , to compare twice- with thrice-daily administration of the same total daily dosage of the long-acting somatostatin analog sms 201-995 ( octreotide , sandoz australia , sydney , australia ) , and to evaluate the risk for cholelithiasis after long-term therapy for acromegaly .
C0028833
octreotide
C0001206
acromegaly